HOME > BUSINESS
BUSINESS
- Takeda’s ALK Drug Yield Positive Update in 1st Line NSCLC
November 26, 2019
- Xofluza Now Available in Taiwan: Shionogi
November 26, 2019
- AnGes to Initiate US Clinical Study for Collategene in Arteriosclerosis Obliterans Patients with Lower Limb Ulcers
November 26, 2019
- Asahi Kasei Pharma Licenses Fasudil to Woolsey; Development of Oral Formulation Expected
November 26, 2019
- Keio Univ. Spin-Off Raises 2.8 Billion Yen to Develop Regenerative Medicine Products for Heart Failure
November 26, 2019
- Mitsubishi Tanabe Kicks Off Multinational PIII of Edaravone Oral Suspension for ALS
November 26, 2019
- Takeda’s Dengue Vaccine Demonstrates Consistent Efficacy in PIII
November 26, 2019
- Sunovion Resubmits Sublingual Parkinson’s Drug in US
November 26, 2019
- AbbVie Enters Japan Oncology Market with Venclexta Rollout
November 25, 2019
- Lung Cancer Drug Portrazza Now Available in Japan: Nippon Kayaku
November 25, 2019
- Takeda R&D Chief Touts Pipeline Revolution, 70% of Research Now in Non-Small Molecules
November 22, 2019
- Parkinson’s Med Haruropi Tape to Hit Shelves on Nov. 29: Kyowa Kirin/Hisamitsu
November 22, 2019
- As BMS Closes Celgene Buy, Japan Integration Gets Underway; 132 Otezla Staffers to Move to Amgen JV
November 22, 2019
- Astellas Links Up with US Health Tech Welldoc in Digital Therapeutics
November 22, 2019
- Evenity Debut, Copycat Entries Set to Jolt Power Map of Japan Osteoporosis Market
November 21, 2019
- Kyowa Kirin Launches Japan PIII for Acoalan in Preeclampsia
November 21, 2019
- Japan’s 1st HIF-PH Inhibitor Hits Market, Kyorin Pushes Back Lasvic Launch amid Desalex Resupply
November 20, 2019
- 70% of Japanese Still Think HIV Is “Deadly Disease”: Gilead Survey
November 20, 2019
- Sumitomo Dainippon to Solely Promote Novartis Diabetes Meds from January
November 20, 2019
- Mitsubishi Chemical to Fully Own Mitsubishi Tanabe to Solidify Healthcare Platform
November 19, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
